Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects
NCT02936154
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
PF-06650833
DRUG:
placebo
Sponsor
Pfizer